SearchDictionaryMobileLogin

Papillary Adenocarcinoma

Subscribe to Selected New Research on Papillary Adenocarcinoma
209  relevant articles (1 outcomes, 8 trials/studies) found for this Disease

Description: An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed)

Also Known As:
Adenocarcinoma, Papillary; Adenocarcinomas, Papillary; Papillary Adenocarcinomas

Relationship Network

Disease Context: Research Results

-
Neoplasms: 387500
-
Neoplasms by Histologic Type: 1
-
Glandular and Epithelial Neoplasms: 238
-
Carcinoma: 89409
-
Adenocarcinoma: 25841
-
Papillary Adenocarcinoma: 209
*
Follicular Papillary Carcinoma

Related Diseases

1. Carcinoma (Carcinomatosis)
2. Neoplasms (Cancer)
3. Adenocarcinoma
4. Adenoma (Adenomas)
5. Hyperplasia

Experts

1. Blanas, K: 1 article (07/2007)
2. Lonsdale, R: 1 article (07/2007)
3. Epurescu, S D: 1 article (07/2007)
4. Nieto, J J: 1 article (07/2007)
5. Burbos, N: 1 article (07/2007)
6. Chang, Yih-Leong: 1 article (06/2006)
7. Lou, Pei-Jen: 1 article (06/2006)
8. Wang, Cheng-Ping: 1 article (06/2006)
9. Yang, Ting-Hua: 1 article (06/2006)
10. Chen, Chin-Tin: 1 article (06/2006)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Papillary Adenocarcinoma:
1. Cisplatin (Platino)FDA LinkGeneric
2. Paclitaxel (Taxol)FDA LinkGeneric
3. Carboplatin (JM8)FDA LinkGeneric
4. irinotecan (Camptosar)FDA LinkGeneric
5. MucinsIBA
6. Keratins (Keratin)IBA
01/01/2005 - "Immunostaining of the tumor cells was positive for cytokeratin (CK) of wide-spectrum screening and for CK 7. The diagnosis of papillary adenocarcinoma of the extrahepatic bile duct was based on the morphologic features of the neoplasm and evidence of local invasion"
01/01/1995 - "Basal cells were positive for high molecular weight cytokeratin in 2 cases of papillary hyperplasia but were missing in papillary adenocarcinoma"
10/01/1992 - "Immunohistochemical staining revealed that elements of the papillary adenocarcinoma were positive for carcinoembryonic antigen, epithelial membrane antigen, keratin, endocrine granule constituent, and CA19-9, while components of the small cell carcinoma were weakly positive only for neuron-specific enolase"
01/01/2001 - "To elucidate the characteristics of NOCS arising from ovarian carcinoma, we investigated the immunohistochemical reactivities of keratin, epithelial membrane antigen(EMA), vimentin, and proliferative cell nuclear antigen(PCNA) in 4 cases of ovarian carcinoma with NOCS(NOCS group), including 3 cases of serous surface papillary adenocarcinoma(SSPC) and 1 case of small ovarian primary serous papillary adenocarcinoma(SPC)"
04/01/1990 - "Primary and metastatic tumor tissues of serous papillary adenocarcinoma of the endometrium were examined for the following: (1) amplification of int-2, c-erbB-2 and c-myc proto-oncogenes by Southern blot hybridization; (2) DNA ploidy by flow cytometric study; (3) and expression of specific proteins, such as estrogen and progesterone receptors, keratin, vimentin, and carcinoembryonic antigen (CEA) using immunohistochemical and biochemical techniques"
Order ALL the reference details at left...
7. Carcinoembryonic AntigenIBA
8. DNA (Deoxyribonucleic Acid)IBA
9. Estrogens (Estrogen)FDA Link
10. VimentinIBA

Therapies and Procedures

1. Photochemotherapy (Photodynamic Therapy)
2. Drug Therapy (Chemotherapy)
3. Thyroidectomy
4. Pancreaticoduodenectomy
5. Heterologous Transplantation (Xenotransplantation)

Best Treatments:
Research Summary Report
on Papillary Adenocarcinoma
*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 1 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>